Showing results (61-70 of 128) with videos related to
Sort By:
Pageof 13
JCI Insight|January 26, 2021
Distinct antibody repertoires against endemic human coronaviruses in children and adultsTaushif Khan, Mahbuba Rahman, Fatima Al Ali, et al.Research Square|March 16, 2022
Neutralizing Type I Interferon Autoantibodies in Japanese Patients With Severe COVID-19Shohei Eto, Yoko Nukui, Miyuki Tsumura, et al.Journal of Clinical Immunology|August 4, 2024
A Novel Case of IFNAR1 Deficiency Identified a Common Canonical Splice Site Variant in DOCK8 in Western Polynesia: The Importance of Validating Variants of Unknown Significance in Under-Represented AncestriesAimee Huynh, Paul E Gray, Anna Sullivan, et al.Journal of Clinical Immunology|June 28, 2022
Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19Shohei Eto, Yoko Nukui, Miyuki Tsumura, et al.Journal of Clinical Immunology|September 27, 2021
Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in BarcelonaXavier Solanich, Raúl Rigo-Bonnin, Victor-David Gumucio, et al.The Journal of Experimental Medicine|September 14, 2011
Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunityYiqi Guo, Magali Audry, Michael Ciancanelli, et al.Ebiomedicine|December 19, 2022
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort studyFabrice Cognasse, Hind Hamzeh-Cognasse, Mickael Rosa, et al.Annals of Intensive Care|December 31, 2022
Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre studyRomain Arrestier, Paul Bastard, Thibaut Belmondo, et al.Nature|March 21, 2024
Role of IL-27 in Epstein-Barr virus infection revealed by IL-27RA deficiencyEmmanuel Martin, Sarah Winter, Cécile Garcin, et al.Journal of Clinical Immunology|May 20, 2023
Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 PneumoniaQuentin Philippot, Arnaud Fekkar, Adrian Gervais, et al.Pageof 13